Active Ingredient(s):Brinzolamide FDA Approved: * April 1, 1998 Pharm Company: *ALCON Category:Vision / Eye Health
Brinzolamide (trade names Azopt, Alcon Laboratories, Befardin, Fardi Medicals, ) is a carbonic anhydrase inhibitor used to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Brinzolamide was approved as a generic medication in the United States in November 2020.
* May have multiple approval dates, manufacturers, or labelers. 1 Discussion